eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2022
vol. 24
 
Share:
Share:
Original paper

Factors affecting health-related quality of life (HRQoL) in Pakistani children with thalassemia

Narjis Batool
1
,
Zikria Saleem
2
,
Hamid Saeed
1
,
Sadia Yasmeen
1
,
Rabia Anwar
1
,
Faheem Ahmad
1
,
Fatima Tauqeer
3
,
Muhammad Bilal Hassan Mahboob
4

1.
University College of Pharmacy, University of the Punjab, Lahore, Pakistan
2.
Hamdard Institute of Pharmaceutical Sciences, Hamdard University, Islamabad, Pakistan
3.
Department of Health and Society, Faculty of Medicine, University of Oslo, Norway
4.
Department of Pharmacy, University of Lahore, Gujrat campus, Gujrat, Pakistan
Family Medicine & Primary Care Review 2022; 24(1): 37–42
Online publish date: 2022/03/27
Get citation
 
PlumX metrics:
 
1. Piel FB, Weatherall DJ. The α-thalassemias. N Engl J Med 2014; 371(20): 1908–1916.
2. Cousens NE, Gaff CL, Metcalfe SA, et al. Carrier screening for beta-thalassaemia: a review of international practice. Eur J Hum Genet 2010; 18(10): 1077–1083.
3. Shakeel M, Arif M, Rehman SU, et al. Investigation of molecular heterogeneity of β-thalassemia disorder in District Charsadda of Pakistan. Pak J Med Sci 2016; 32(2): 491–494.
4. Maheen H, Malik F, Siddique B, et al. Assessing Parental Knowledge About Thalassemia in a Thalassemia Center of Karachi, Pakistan. J Genet Couns 2015; 24(6): 945–951.
5. Thavorncharoensap M, Torcharus K, Nuchprayoon I, et al. Factors affecting health-related quality of life in Thai children with thalassemia. BMC Blood Disord 2010; 10: 1, doi: 10.1186/1471-2326-10-1.
6. Caro JJ, Ward A, Green TC, et al. Impact of thalassemia major on patients and their families. Acta Haematol 2002; 107(3): 150–157.
7. Toumba M, Sergis A, Kanaris C, et al. Endocrine complications in patients with Thalassaemia Major. Pediatr Endocrinol Rev 2007; 5(2): 642–648.
8. Chern JP, Su S, Lin KH, et al. Survival, mortality, and complications in patients with β‐Thalassemia major in northern Taiwan. Pediatr Blood Cancer 2007; 48(5): 550–554.
9. Al-Elq AH, Al-Saeed HH. Endocrinopathies in patients with thalassemias. Saudi Med J 2004; 25(10): 1347–1351.
10. De Sanctis V, Roos M, Gasser T, et al. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia. J Pediatr Endocrinol Metab 2006; 19(4): 471–480.
11. Shamshirsaz AA, Bekheirnia MR, Kamgar M, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord 2003; 3(1): 4.
12. Malik S, Syed S, Ahmed N. Complications in transfusion-dependent patients of ß-thalassemia major. Pak J Med Sci 2009; 25(4): 678–682.
13. Prati D, Maggioni M, Milani S, et al. Clinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 cases. Haematologica 2004; 89(10): 1179–1186.
14. Mazzone L, Battaglia L, Andreozzi F, et al. Emotional impact in β-thalassaemia major children following cognitive-behavioural family therapy and quality of life of caregiving mothers. Clin Pract Epidemiol Ment Health 2009; 5: 5, doi: 10.1186/1745-0179-5-5.
15. Gharaibeh H, Gharaibeh M. Factors influencing health‐related quality of life of thalassaemic Jordanian children. Child Care Health Dev 2012; 38(2): 211–218.
16. Mikelli A, Tsiantis J. Brief report: depressive symptoms and quality of life in adolescents with b-thalassaemia. J Adolesc 2004; 27(2): 213–216.
17. Ismail A, Campbell MJ, Ibrahim HM, et al. Health related quality of life in Malaysian children with thalassaemia. Health Qual Life Outcomes 2006; 4: 39.
18. Pakbaz Z, Treadwell M, Yamashita R, et al. Quality of life in patients with thalassemia intermedia compared to thalassemia major. Ann N Y Acad Sci 2005; 1054: 457–461.
19. Abetz L, Baladi J-F, Jones P, et al. The impact of iron overload and its treatment on quality of life: results from a literature review. Health Qual Life Outcomes 2006; 4: 73.
20. Shaligram D, Girimaji S, Chaturvedi S. Psychological problems and quality of life in children with thalassemia. Indian J Pediatr 2007; 74(8): 727–730.
21. Telfer P, Constantinidou G, Andreou P, et al. Quality of life in thalassemia. Ann N Y Acad Sci 2005; 1054: 273–282.
22. Ammad SA, Mubeen SM, Shah SFUH, et al. Parents’ opinion of quality of life (QoL) in Pakistani thalassaemic children. J Pak Med Assoc 2011; 61(5): 470–473.
23. Kotrlik J, Higgins C. Organizational research: determining appropriate sample size in survey research appropriate sample size in survey research. Information Technology, Learning, and Performance Journal 2001; 19(1): 43.
24. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118(8): 622–629.
25. Pal DK. Quality of life assessment in children: a review of conceptual and methodological issues in multidimensional health status measures. J Epidemiol Community Health 1996; 50(4): 391–396.
26. Varni JW, Seid M, Rode CA. The PedsQL™: measurement model for the pediatric quality of life inventory. Med Care 1999; 37(2): 126–139.
27. Varni JW, Seid M, Kurtin PS. Pediatric health-related quality of life measurement technology: a guide for health care decision makers. J Clin Outcomes Manag 1999; 6: 33–44.
28. Netuveli G, Blane D. Quality of life in older ages. Br Med Bull 2008; 85: 113–126.
29. Dolai TK, Dutta S, Bhattacharyya M, et al. Prevalence of hemoglobinopathies in rural Bengal, India. Hemoglobin 2012; 36(1): 57–63.
30. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004; 89(10): 1187–1193.
31. Nielsen P, Günther U, Dürken M, et al. Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance. J Lab Clin Med 2000; 135(5): 413–418.
32. Oktenli C, Bulucu F. Renal tubular dysfunction in a patient with beta-thalassemia minor. Nephron 2002; 92(1): 222–223.
33. Rasool M, Malik A, Jabbar U, et al. Effect of iron overload on renal functions and oxidative stress in beta thalassemia patients. Saudi Med J 2016; 37(11): 1239–1242.
34. Arosio P, Levi S. Ferritin, iron homeostasis, and oxidative damage 1, 2. Free Radic Biol Med 2002; 33(4): 457–463.
Copyright: © 2022 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.